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A B S T R A C T
A 47-year-old male was admitted to hospital for severe pericardial effusion; he had undergone surgical
removal of cutaneous melanoma 10 years before. Echocardiography-guided pericardiocentesis revealed
the presence of intramyocardial masses, which were better deﬁned and characterized, together with
pericardial involvement, by cardiac magnetic resonance. Pericardial ﬂuid drained was negative for
malignant cells, so video-assisted thoracoscopy was performed and pathologic tissue was biopsied,
leading to the diagnosis of metastatic melanoma. Multidisciplinary approach and multimodality
imaging played a key role in allowing the diagnostic workup in this complex case.
<Learning objective: The diagnosis of cardiac metastases is challenging and histologic characterization
is necessary to guide therapy. Multimodality imaging and minimally invasive thoracoscopy are key tools
to achieve these goals.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Cardiac metastases often remain silent, being an autoptic ﬁnding;
when symptomatic they can mimic all forms of cardiac disease,
ranging from dyspnea, to atrial and ventricular arrhythmias, to chest
pain, and represent an insidious diagnostic challenge. Melanoma is the
solid tumor with the highest propensity to hematogenous spread to
the heart. The integration of cardiac imaging modalities with
multidisciplinary approach is the prominent feature in managing
complex cases with both systemic and cardiac neoplastic involvement.
Minimally invasive thoracoscopy can allow biopsy of cardiac masses,
thus permitting histologic diagnosis and therapy planning.
Case report
A 47-year-old male was admitted to hospital for worsening
dyspnea. Ten years earlier he had undergone surgical removal of
cutaneous melanoma of the dorsal region, with lymphadenectomy;
regular follow-up had been negative for disease recurrence. At* Corresponding author at: Ospedale Niguarda Ca` Granda, P.zza Ospedale
Maggiore, 3, 20162 Milano, Italy. Tel.: +39 02 64444584; fax: +39 02 64444662;
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1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightshospital admission, electrocardiogram (ECG) showed sinus
tachycardia with normal atrioventricular (A-V) conduction, QRS
voltage tended to be low and diffuse repolarization abnormalities
were present (Fig. 1, Panel A). Echocardiography revealed severe
pericardial effusion, with initial signs of ventricular ﬁlling
impairment; pericardiocentesis evacuated 1600 ml of citrine-
yellow pericardial ﬂuid, negative for malignant cells. Moderate
pericardial effusion persisted, and lateral and inferolateral wall
thickening was detected at echocardiography (Fig. 2, Panels A and
B); a mass of 2 cm was seen on the right side of the interatrial
septum (Fig. 2, Panels C and D). Cardiac magnetic resonance (CMR)
showed diffuse thickening of the left ventricle, more pronounced
on the lateral side (Fig. 3, Panel A) and inferolateral walls.
Pathologic myocardial segments showed inhomogeneous, hyper-
intense signals both on STIR-T2 and on T1 images (Fig. 3, Panels B
and C), and were perfused at ﬁrst-pass contrast injection and
enhanced inhomogeneously (Fig. 3, Panel D). The coronary sinus
was occupied by pathologic solid tissue, protruding for 2 cm in the
right atrium beside the interatrial septum and sharing the same
signal characteristics of the masses inﬁltrating ventricular
myocardium (Fig. 3, Panels A–D). Multiple solid tissue nodules
were identiﬁed on the parietal pericardium. Severe pericardial
effusion was present (Fig. 3, Panel A), with initial signs of
hemodynamic relevance. A pericardial window was created via
video-assisted thoracoscopy; multiple biopsies of pericardial reserved.
Fig. 1.
Panel A: electrocardiogram (ECG) at admission, showing sinus tachycardia, with normal atrioventricular (A-V) conduction, low QRS voltage and diffuse
repolarization abnormalities. Panel B: ECG at discharge, showing sinus rhythm with normal A-V conduction. QRS voltage had improved, although lack of
progression of the R wave in the precordial leads is more evident compared to admittance ECG; some abnormalities of repolarization were still present.
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left in situ. Total body computed tomography (CT) scan showed
small pulmonary nodules. A cutaneous lesion was noticed on the
head and biopsied. Histologic examination of both the cutaneous
mass and the pericardial nodules revealed epithelioid cell-type
melanoma, showing BRAF mutation (B-Raf proto-oncogene,
serine/threonine kinase); the cutaneous lesion was judged as
metastatic. BRAF mutation is frequently  found in melanoma and
speciﬁc therapy with oral vemurafenib, a small molecular
inhibitor, has proven effective in advanced (stage 4) BRAF-
mutant melanoma [1]. Therapy with vemurafenib was started
and well tolerated. ECG monitoring during hospital stay did not
reveal any signiﬁcant arrhythmias. ECG at discharge showed
sinus rhythm with normal A-V conduction. QRS voltage had
improved, although lack of progression of the R wave in the
precordial leads was more evident compared to admittance ECG;
some abnormalities of repolarization were still present (Fig. 1,
Panel B).Discussion
Malignant melanomas represent the tumors with the highest
rate of cardiac involvement [2]. Cardiac metastases usually
remain silent; when symptomatic, they can mimic all forms of
cardiac disease, ranging from dyspnea, to atrial and ventricular
arrhythmias, to chest pain [3]. The ﬁrst sign of cardiac
involvement can be cardiac tamponade. Imaging has a pivotal
role in better deﬁning location, extension, and hemodynamic
consequences of cardiac metastases. Echocardiography detects
myocardial and pericardial masses and pericardial effusion; its
role in the emergency setting of cardiac tamponade is well
established [2] while it cannot unequivocally establish the
nature of cardiac masses or pericardial effusion. CMR allows
comprehensive evaluation of the heart muscle, pericardium and
surrounding organs; its capacity of tissue characterization
permits the identiﬁcation of pathologic tissue within the cardiac
muscle and pericardium [4]. First-pass perfusion imaging and
Fig. 2.
Panels A and B: parasternal view (long and short axis): left ventricular lateral and inferolateral mid and basal wall thickening (3.4 cm; lower arrow); pericardial
effusion (upper arrow). Panels C and D: parasternal view (aortic plane) and four-chamber view: round mass protruding on the right side of the interatrial septum
(arrow).
Fig. 3.
Four-chamber off-axis view, end-diastolic phase. Panel A: cine image. Thickening of the lateral basal wall (long arrow) of the left ventricle; mass protruding in the
right atrium, in proximity of the interatrial septum (short arrow); the coronary sinus is entirely occupied by pathologic tissue (asterisk); severe pericardial
effusion. Panel B: STIR T2-weighted image, showing inhomogeneously hyperintense signal of the pathologic masses and hyperintense signal of the pericardium
(arrows). Panel C: T1-weighted image, showing inhomogeneously hyperintense signal of the pathologic masses (arrows). Panel D: post-contrast image, showing
inhomogeneous enhancement of the pathologic mass inﬁltrating the left ventricular wall. LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.
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Melanoma signal characteristics are dictated by the content
in melanin, a natural paramagnetic substance [5] causing
T1 shortening, thus generating high signal on T1-images and
low-signal on T2-images. This classic ﬁnding is present only in
a minority of cases. In most cases the signal is inhomogen-
eously hyperintense both on T1 and T2-images [4]. Usually
melanoma metastases show diffuse post-contrast enhance-
ment. Cardiac CT allows disease staging and can identify
hemorrhagic pericardial effusion; 18F-ﬂuorodeoxyglucose
positron emission tomography (FDG/PET) can distinguish
pathologic areas from normal myocardial tissue, and can be
combined with CT, to integrate metabolic and anatomic
information [6].
Histologic characterization of neoplastic masses is neces-
sary to guide therapy. Pericardial ﬂuid can contain malignant
cells; if examination of pericardial ﬂuid is negative, pathologic
lesions should be biopsied. Histologic characterization of
the tumor led to the prescription of state-of-the-art therapy
for BRAF-mutated melanoma, although 1-year prognosis
remains severe. A multidisciplinary approach played a key
role in the diagnostic workup and management of this complex
case.
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